FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

1217219000: Tenofovir disoproxil succinate (substance)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 30-Apr 2022. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
5035174018 Tenofovir disoproxil succinate (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
5035175017 Tenofovir disoproxil succinate en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Tenofovir disoproxil succinate (substance) Is a Reverse transcriptase inhibitor true Inferred relationship Some
Tenofovir disoproxil succinate (substance) Is a Carboxylic ester (substance) true Inferred relationship Some
Tenofovir disoproxil succinate (substance) This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. Reverse transcriptase inhibitor (disposition) true Inferred relationship Some
Tenofovir disoproxil succinate (substance) This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. Tenofovir disoproxil (substance) true Inferred relationship Some
Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing precisely emtricitabine 200 milligram and tenofovir disoproxil (as tenofovir disoproxil succinate) 245 milligram/1 each conventional release oral tablet (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Tenofovir disoproxil succinate (substance) Inferred relationship Some 2
Product containing precisely efavirenz 600 milligram and emtricitabine 200 milligram and tenofovir disoproxil (as tenofovir disoproxil succinate) 245 milligram/1 each conventional release oral tablet (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Tenofovir disoproxil succinate (substance) Inferred relationship Some 3

This concept is not in any reference sets

Back to Start